Total Payments
$6,685
2024 Payments
$774.61
Companies
23
Transactions
243
Medicare Patients
19,762
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$4,389 (65.7%)
Consulting$1,200 (18.0%)
Education$595.31 (8.9%)
Other$500.00 (7.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,389 | 230 | 65.7% |
| Consulting Fee | $1,200 | 1 | 18.0% |
| Education | $595.31 | 11 | 8.9% |
| Honoraria | $500.00 | 1 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,799 | 11 | $0 (2023) |
| ABBVIE INC. | $710.74 | 47 | $0 (2024) |
| Lilly USA, LLC | $703.32 | 48 | $0 (2024) |
| Medline Industries, Inc. | $500.00 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $424.71 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $374.06 | 23 | $0 (2022) |
| GENZYME CORPORATION | $296.27 | 15 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $282.19 | 12 | $0 (2022) |
| Galderma Laboratories, L.P. | $205.19 | 11 | $0 (2024) |
| Celgene Corporation | $196.67 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $774.61 | 38 | Regeneron Healthcare Solutions, Inc. ($210.16) |
| 2023 | $673.46 | 33 | Regeneron Healthcare Solutions, Inc. ($167.86) |
| 2022 | $987.88 | 42 | Sun Pharmaceutical Industries Inc. ($208.06) |
| 2021 | $348.08 | 19 | Janssen Biotech, Inc. ($88.09) |
| 2020 | $1,467 | 10 | Janssen Biotech, Inc. ($1,358) |
| 2019 | $639.65 | 42 | Lilly USA, LLC ($165.23) |
| 2018 | $715.35 | 26 | Janssen Biotech, Inc. ($216.99) |
| 2017 | $1,079 | 33 | Medline Industries, Inc. ($500.00) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $85.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $9.90 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.75 | General |
| Category: Immunology | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.54 | General |
| Category: Immunology | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $15.96 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.04 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ACNE | ||||||
| 07/18/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 07/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Immunology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: DERMATOLOGY | ||||||
| 05/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,822 | 9,571 | $555,825 | $344,927 |
| 2022 | 31 | 4,843 | 10,761 | $572,145 | $347,646 |
| 2021 | 28 | 5,190 | 11,830 | $579,621 | $377,484 |
| 2020 | 23 | 4,907 | 11,678 | $565,477 | $324,242 |
Total Patients
19,762
Total Services
43,840
Medicare Billing
$1.4M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 302 | 414 | $72,495 | $45,679 | 63.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 712 | 783 | $70,092 | $44,358 | 63.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 64 | 72 | $46,847 | $35,384 | 75.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 874 | 972 | $67,436 | $35,159 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 284 | $35,299 | $23,767 | 67.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 543 | 761 | $30,108 | $19,680 | 65.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 709 | 4,363 | $37,914 | $19,255 | 50.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 231 | 245 | $27,149 | $16,893 | 62.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 40 | 52 | $20,556 | $16,116 | 78.4% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 81 | 91 | $18,069 | $12,325 | 68.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 187 | 198 | $19,761 | $12,113 | 61.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 172 | 172 | $18,898 | $11,813 | 62.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 77 | 81 | $14,090 | $9,749 | 69.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 73 | 84 | $14,500 | $9,016 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $12,054 | $7,554 | 62.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 48 | 49 | $9,145 | $6,491 | 71.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 51 | 53 | $6,896 | $3,913 | 56.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 21 | 21 | $7,350 | $2,495 | 34.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 60 | 60 | $4,750 | $2,434 | 51.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 25 | $3,561 | $2,333 | 65.5% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 14 | $2,596 | $1,890 | 72.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 67 | $3,830 | $1,838 | 48.0% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $2,559 | $1,502 | 58.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 77 | $770.00 | $646.80 | 84.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 17 | $872.04 | $644.96 | 74.0% |
About Dr. Robert Aylesworth, MD
Dr. Robert Aylesworth, MD is a Dermatology healthcare provider based in Rhinelander, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356397699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Aylesworth, MD has received a total of $6,685 in payments from pharmaceutical and medical device companies, with $774.61 received in 2024. These payments were reported across 243 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,389).
As a Medicare-enrolled provider, Aylesworth has provided services to 19,762 Medicare beneficiaries, totaling 43,840 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Rhinelander, WI
- Active Since 05/26/2006
- Last Updated 04/21/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356397699
Products in Payments
- TREMFYA (Drug) $1,545
- TALTZ (Drug) $586.25
- DUPIXENT (Biological) $540.83
- COSENTYX (Biological) $359.72
- Tremfya (Drug) $339.08
- RINVOQ (Biological) $275.76
- BOTOX (Biological) $214.67
- SKYRIZI (Biological) $196.52
- Erivedge (Biological) $166.23
- Sotyktu (Drug) $163.76
- ILUMYA (Biological) $141.80
- Otezla (Drug) $139.82
- Humira (Biological) $105.61
- Bimzelx (Biological) $81.79
- DERMATITIS - DISEASE (Drug) $72.99
- EUCRISA (Drug) $69.32
- LIBTAYO (Biological) $64.24
- EPIDUO FORTE (Drug) $63.39
- Cimzia (Drug) $55.58
- Ameluz (Drug) $44.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.